Abstract
Body composition and body mass are pivotal clinical endpoints in studies of welfare diseases. We present a combined effort of established and new mathematical models based on rigorous monitoring of energy intake (EI) and body mass in mice. Specifically, we parameterize a mechanistic turnover model based on the law of energy conservation coupled to a drug mechanism model. Key model variables are fat-free mass (FFM) and fat mass (FM), governed by EI and energy expenditure (EE). An empirical Forbes curve relating FFM to FM was derived experimentally for female C57BL/6 mice. The Forbes curve differs from a previously reported curve for male C57BL/6 mice, and we thoroughly analyse how the choice of Forbes curve impacts model predictions. The drug mechanism function acts on EI or EE, or both. Drug mechanism parameters (two to three parameters) and system parameters (up to six free parameters) could be estimated with good precision (coefficients of variation typically <20 % and not greater than 40 % in our analyses). Model simulations were done to predict the EE and FM change at different drug provocations in mice. In addition, we simulated body mass and FM changes at different drug provocations using a similar model for man. Surprisingly, model simulations indicate that an increase in EI (e.g. 10 %) was more efficient than an equal lowering of EI. Also, the relative change in body mass and FM is greater in man than in mouse at the same relative change in either EI or EE. We acknowledge that this assumes the same drug mechanism impact across the two species. A set of recommendations regarding the Forbes curve, vehicle control groups, dual action on EI and loss, and translational aspects are discussed. This quantitative approach significantly improves data interpretation, disease system understanding, safety assessment and translation across species.
Similar content being viewed by others
References
Torgerson JS, Hauptman J, Boldrin MN, Sjöström L (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27(1):155–61
Kang JG, Park CY (2012) Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 36(1):13–25
Jusko WJ, Ko HC, Ebling WF (1995) Convergence of direct and indirect pharmacodynamic response models. J Pharmacokinet Biopharm 23:5–8
Danhof M, Alvan G, Dahl SG, Kuhlmann J, Paintaud G (2005) Mechanism-based pharmacokinetic-pharmacodynamic modeling: a new classification of biomarkers. Pharm Res 22(9):1432–7
Guo J, Hall KD (2009) Estimating the continuous-time dynamics of energy and fat metabolism in mice. PLoS Comput Biol 5(9):e1000511
Guo J, Hall KD (2011) Predicting changes of body weight, body fat, energy expenditure and metabolic fuel selection in C57BL/6 mice. PLoS One 6(1):e15961
Ellacott KL, Morton GJ, Woods SC, Tso P, Schwartz MW (2010) Assessment of feeding behavior in laboratory mice. Cell Metab 12(1):10–7
Gabrielsson J, Weiner D (2010) Pharmacokinetic & pharmacodynamic, data analysis, concepts and applications, 4th edn. 2nd print, Swedish Pharmaceutical Press, Stockholm. ISBN-139789197651004
Westertep K, Donkers J, Fredrix E, Boekhoudt P (1995) Energy intake, physical activity and body weight: a simulation model. Br J Nutr 73:337–347
Christiansen E, Garby L (2002) Prediction of body weight changes caused by changes in energybalance. Eur J Clin Invest 32:826–30
Christiansen E, Garby L, Sørensen TIA (2005) Quantitative analysis of the energy requirements for development of obesity. J Theor Biol 234:99–106
Hall KD (2006) Computational model of in vivo human energy metabolism during semi starvation and refeeding. Am J Physiol Endocrinol Metab 291:E23–27
Chow CC, Hall KD (2008) The dynamics of human body weight change. PLoS Comput Biol 4(3):e1000045
Hall KD, Jordan PN (2008) Modeling weight-loss maintenance to help prevent body weight regain. Am J Clin Nutr 88(6):1495–503
Hou C, Zuo W, Moses ME, Woodruff WH, Brown JH, West GB (2008) Energy uptake and allocation during ontogeny. Sci Agric 322(5902):736–9
Thomas DM, Ciesla A, Levine JA, Stevens JG, Martin CK (2009) A mathematical model of weight change with adaptation. Math Biosci Eng 6(4):873–887
Landersdorfer CB, DuBois DC, Almon RR, Jusko WJ (2009) Mechanism-based modeling of nutritional and leptin influences on growth in normal and type 2 diabetic rats. J Pharmacol Exp Ther 328(2):644–51
Hall KD (2010) Predicting metabolic adaptation, body weight change, and energy intake in humans. Am J Physiol Endocrinol Metab 298(3):E449–66
Navarro-Barrientos JE, Rivera DE, Collins LM (2011) A dynamical model for describing behavioural interventions for weight loss and body composition change. Math Comput Model Dyn Syst 17(2):183–203
Hall KD (2011) Quantification of the effect of energy imbalance on bodyweight. Lancet 378:826–37
Hall KD (2008) What is the required energy deficit per unit weight loss?. Int J Obes (Lond) 32:573–576
Forbes GB (1987) Lean body mass-body fat interrelationships in humans. Nutr Rev 45:225–231
Forbes GB (2000) Body fat content influences the body composition response to nutrition and exercise. Ann N Y Acad Sci 904:359–365
Hall KD (2010) Mathematical modelling of energy expenditure during tissue deposition. Br J Nutr 104:4–7
Kleiber M (1975) The fire of life: an introduction to animal energetics. Robert E Krieger Publishing Company, Malabar
Guo J, Jou W, Gavrilova O, Hall KD (2009) Persistent diet-induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One 4:e5370
Johansson CC, Gennemark P, Artursson P, Äbelö A, Ashton M, Jansson-Löfmark R (2013) Population pharmacokinetic modeling and deconvolution of enantioselective absorption of eflornithine in the rat. J Pharmacokinet Pharmacodyn 40(1):117–28
Vickers SP, Jackson HC, Cheetham SC (2011) The utility of animal models to evaluate novel anti-obesity agents. Br J Pharmacol 164(4):1248–62
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gennemark, P., Jansson-Löfmark, R., Hyberg, G. et al. A modeling approach for compounds affecting body composition. J Pharmacokinet Pharmacodyn 40, 651–667 (2013). https://doi.org/10.1007/s10928-013-9337-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10928-013-9337-x